SW
NKGN

SkyOak Wealth’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

SkyOak Wealth’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,164
Closed -$8.63K – 280
2024
Q4 		$8.63K Buy
+13,164
New +$5.37K ﹤0.01% 252

Other funds holding NKGN

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

SkyOak Wealth's NKGN Position: Q1 2025 in Review

SkyOak Wealth sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 13,164 shares — an estimated $8.63K sold.

SkyOak Wealth first reported a position in NKGN in Q4 2024 and held it in 1 quarter. The position peaked at $8.63K in Q4 2024. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

  • SkyOak Wealth reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SkyOak Wealth sold 13,164 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $8.63K.
  • SkyOak Wealth first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • SkyOak Wealth's NKGen Biotech, Inc. Common Stock position peaked at $8.63K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on SkyOak Wealth's 13F filing for Q1 2025, filed 1 May 2025.